Next Article in Journal
Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art
Previous Article in Journal
Challenges in Geriatric Oncology—A Surgeon’s Perspective
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 29
Issue 2
10.3390/curroncol29020059
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Acknowledgment to Reviewers of Current Oncology in 2021

by
Current Oncology Editorial Office
MDPI AG, St. Alban-Anlage 66, 4052 Basel, Switzerland
Curr. Oncol. 2022, 29(2), 675-686; https://doi.org/10.3390/curroncol29020059
Published: 29 January 2022
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Rigorous peer-reviews are the basis of high-quality academic publishing [...]

Share and Cite

MDPI and ACS Style

Current Oncology Editorial Office. Acknowledgment to Reviewers of Current Oncology in 2021. Curr. Oncol. 2022, 29, 675-686. https://doi.org/10.3390/curroncol29020059

AMA Style

Current Oncology Editorial Office. Acknowledgment to Reviewers of Current Oncology in 2021. Current Oncology. 2022; 29(2):675-686. https://doi.org/10.3390/curroncol29020059

Chicago/Turabian Style

Current Oncology Editorial Office. 2022. "Acknowledgment to Reviewers of Current Oncology in 2021" Current Oncology 29, no. 2: 675-686. https://doi.org/10.3390/curroncol29020059

APA Style

Current Oncology Editorial Office. (2022). Acknowledgment to Reviewers of Current Oncology in 2021. Current Oncology, 29(2), 675-686. https://doi.org/10.3390/curroncol29020059

Article Metrics

Back to TopTop